Welcome to DigitexMedwire Research

Friends, we are so happy and excited to introduce our first ever blogging platform dedicated to Global healthcare industry. With global economy growing at 4% and world healthcare industry growing at an impressive rate of 17% annually, our team couldn’t manage a better time than now to share our knowledge tank with you people. Dear partners, friends, customers, well wishers and society in general, you can expect us bring you the best articles, write ups, news columns, reports and events update on cutting edge technologies and latest lifestyle trends in the Indian and International markets. This blog is an interim platform for leaders in making and leaders in practice who pursue ‘knowledge’ as their platform to success. This blog site is a product of DMSMedwire Research ‘knowledge sharing program’ and is a signature to our long term business expansion plans and corporate identity.

We wish all our fellow readers, best of luck. Happy Reading!

Thursday, September 18, 2008

Frost & Sullivan Award Recognises TietoEnator's Exceptional Product Differentiation Innovation


The 2008 Frost & Sullivan European Laboratory Information Systems Product Differentiation Innovation Award is conferred on TietoEnator for continuously innovating and upgrading individual disciplines of laboratory information systems (LIS) technology. Diverse healthcare IT solutions, uncompromising customer support and focused innovation contribute to TietoEnator's success.
"TietoEnator's deep understanding of customer requirements, the provision of complete healthcare IT solutions, and strategic technology upgrades have enabled the company to capture nearly 47.5 per cent of revenues in the LIS market in Scandinavia in 2007-2008," notes Frost & Sullivan Research Analyst Shriram Shanmugham. "TietoEnator clearly understands that in a mature LIS market, it is imperative that existing customers be satisfied and individual LIS disciplines experience technological innovation at regular intervals."
Quality customer service and support have been central to the company's success. TietoEnator endeavours to constantly enhance the lab operator's competency in using the LIS product. The company-client relationship is unique and built on a system of continuous feedback. With demand surging, TietoEnator is currently working to boost its LIS product development workforce capacity.
The company also offers a broad portfolio of outstanding healthcare IT solutions. It is one among two companies in Scandinavia that provides LIS management solutions to all disciplines (hematology, microbiology, cytology, etc) supported by hospital laboratories. In addition to LIS, TietoEnator also provides a reliable hospital information system (HIS) module.
"With installations across nearly half of Scandinavia's hospitals, patient data can be easily shared among hospitals that have TietoEnator's products," remarks Shanmugham. "Moreover, hospitals in Scandinavia consider seller reputation an important criteria for choosing an LIS; the exceptional performance of TietoEnator's products is encouraging hospitals to invest in the company's solutions."
Hospitals are subjected to paying 200,000 to 1,000,000 for licensing the LIS module from TietoEnator. TietoEnator understands that it is risky to introduce an entirely new LIS for a replacement. Instead, it provides upgrades or new versions for the sub-disciplines of a basic laboratory operation.
"For instance, during the first year of installation, TietoEnator will provide an upgrade to the hematology division and for the successive year, it may provide a new version of technology solution for the cytology discipline," explains Shanmugham. "While the lifecycle of most LIS modules ranges between 8 to 10 years, the LIS module provided by TietoEnator -- thanks to its strategic technological upgrades -- lasts for 12 to 15 years."
Currently, TietoEnator is developing an upgrade to a new lab discipline -- genetic health control. This is a specific diagnostic tool used in a hospital laboratory to screen symptoms of cancer. It is particularly aimed at monitoring women's health in Scandinavia.

Source: marketwatch.com Contributed by: DMSMedwire Team

No comments: